Synapse

← Deepak L. Bhatt

Papers by Deepak L. Bhatt

Page 3 · newest first

  1. Long‐Term Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists in Patients With Peripheral Artery Disease and Type 2 DiabetesJournal of the American Heart Association · 2026
  2. Effect of Colchicine on Left Atrial Mechanics in Rheumatic Heart DiseaseJACC Asia · 2026
  3. Left Atrial Appendage Closure vs Anticoagulation for Stroke Prevention in Atrial FibrillationJACC. Clinical electrophysiology · 2026
  4. Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary SyndromesJournal of the American College of Cardiology · 2015
  5. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery DiseaseJournal of the American College of Cardiology · 2016
  6. Allograft VasculopathyJournal of the American College of Cardiology · 2016
  7. Role of systemic and epicardial adipose tissue in cardiometabolic diseaseNature Reviews Cardiology · 2026
  8. Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?European Heart Journal · 2018
  9. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID UseJournal of the American College of Cardiology · 2008
  10. Competing Risks in Clinical TrialsJournal of the American College of Cardiology · 2024
  11. ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement EnterpriseJournal of the American College of Cardiology · 2015
  12. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial InfarctionJournal of the American College of Cardiology · 2017
  13. 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular DiseaseJournal of the American College of Cardiology · 2020
  14. Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery DiseaseJournal of the American College of Cardiology · 2021
  15. The emerging role of coronary computed tomography for prevention of cardiovascular disease in asymptomatic individualsEuropean Journal of Preventive Cardiology · 2026
  16. Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary InterventionJournal of the American College of Cardiology · 2023
  17. Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial FibrillationJournal of the American College of Cardiology · 2025
  18. Trial Design Principles for Patients at High Bleeding Risk Undergoing PCIJournal of the American College of Cardiology · 2020
  19. P3670Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54European Heart Journal · 2017
  20. Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet FunctionJournal of the American College of Cardiology · 2013
  21. Performance of Local Large Language Models for Adjudicating Heart Failure HospitalizationsCirculation · 2026
  22. Rural-Urban Disparity in Postacute Care and 1-Year Outcomes After Ischemic StrokeStroke · 2026
  23. Lipoprotein(a) Levels and Time to Cardiovascular Benefit With Alirocumab in Patients With Recent Acute Coronary SyndromeJournal of the American College of Cardiology · 2025
  24. Herpes zoster vaccine effectiveness against cardiovascular events - a systematic literature review and meta-analysisEuropean Heart Journal · 2025
  25. A polygenic risk score predicts atrial fibrillation in cardiovascular diseaseEuropean Heart Journal · 2022
  26. Palliative Care Use in Patients With Acute Myocardial InfarctionJournal of the American College of Cardiology · 2020
  27. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive SummaryJournal of the American College of Cardiology · 2021
  28. A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial.2026
  29. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass SurgeryJournal of the American College of Cardiology · 2019
  30. Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54Journal of the American College of Cardiology · 2017
  31. Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failureEuropean Heart Journal · 2014
  32. Abbreviated dual antiplatelet therapy after PCI in patients at high bleeding risk: a collaborative meta-analysis of randomized trialsEuropean Heart Journal · 2022
  33. Recurrent Events in Cardiovascular TrialsJournal of the American College of Cardiology · 2023
  34. Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 modelEuropean Heart Journal · 2026
  35. Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS TrialJournal of the American College of Cardiology · 2019
  36. ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID UseJournal of the American College of Cardiology · 2010
  37. Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular DiseaseJournal of the American College of Cardiology · 2024
  38. P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary EventsJournal of the American College of Cardiology · 2023
  39. Impact of Renal Denervation on 24-Hour Ambulatory Blood PressureJournal of the American College of Cardiology · 2014
  40. Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y ₁₂ inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54European Heart Journal · 2015
  41. Secondary Prevention After Myocardial Infarction in the United StatesJournal of the American College of Cardiology · 2026
  42. Long-Term Cardiovascular Risk in Women With Hypertension During PregnancyJournal of the American College of Cardiology · 2019
  43. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registryEuropean Heart Journal · 2014
  44. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery DiseaseJournal of the American College of Cardiology · 2018
  45. 2350Evaluation of the pharmacodynamics of a ticagrelor reversal agent PB2452European Heart Journal · 2019
  46. Lack of Association Between Heart Failure and Incident CancerJournal of the American College of Cardiology · 2018
  47. Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 PandemicJournal of the American College of Cardiology · 2020
  48. Early Aspirin Discontinuation Following PCI for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of Reconstructed Individual Patient DataJournal of the Society for Cardiovascular Angiography & Interventions · 2026
  49. Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactEuropean Heart Journal · 2026
  50. Heart Failure With Preserved, Borderline, and Reduced Ejection FractionJournal of the American College of Cardiology · 2017